目录
- Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018 (English version)
- Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version)
- An update on biomarkers of potential benefit with bevacizumab for breast cancer treatment: Do we make progress?
- Association of cancer prevention awareness with esophageal cancer screening participation rates: Results from a populationbased cancer screening program in rural China
- FAT1, a direct transcriptional target of E2F1, suppresses cell proliferation, migration and invasion in esophageal squamous cell carcinoma
- Clinical significance of MET gene amplification in metastatic or locally advanced gastric cancer treated with first-line fluoropyrimidine and platinum combination chemotherapy
- A 18FDG PET/CT-based volume parameter is a predictor of overall survival in patients with local advanced gastric cancer
- Radiomics-based predictive risk score: A scoring system for preoperatively predicting risk of lymph node metastasis in patients with resectable non-small cell lung cancer
- Changing patterns and survival improvements of young breast cancer in China and SEER database, 1999-2017
- Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China
- Evaluation of COC183B2 antibody targeting ovarian cancer by near-infrared fluorescence imaging
- An enrichment model using regular health examination data for early detection of colorectal cancer
- Identification of cancer patients using claims data from health insurance systems: A real-world comparative study